Treatment toxicity reduction: breast cancer
- 31 December 1987
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 14 (3-4) , 263-274
- https://doi.org/10.1016/0305-7372(87)90017-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Short-term chemotherapy of poor-prognosis metastatic breast cancer with three non-cross resistant chemotherapy regimens. A southwest oncology group studyCancer, 1987
- A phase I and pharmacology study of continuous-infusion low-dose methotrexate administrationCancer, 1985
- Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patientsCancer, 1985
- Five-day continuous-infusion vinblastine in the treatment of breast cancerCancer, 1985
- A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancerInvestigational New Drugs, 1985
- Multivariate analysis of prognostic factors in metastatic breast cancer.Journal of Clinical Oncology, 1983
- Prognostic Factors in the Initial Response to Therapy by Patients With Advanced Breast Cancer 2JNCI Journal of the National Cancer Institute, 1978
- Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group studyCancer, 1976
- An analysis of a multiple‐drug program in the treatment of patients with advanced breast cancer utilizing 5‐fluorouracil, cyclophosphamide, and prednisone with or without vincristineCancer, 1975
- Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancerCancer, 1974